Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements-Reference-Cited by-同舟云学术

Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements

Published:2008-04 Issue:2 Volume:182 Page:111-115
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

De Melo Valeria A.S.,Milojkovic Dragana,Marin David,Apperley Jane F.,Nacheva Elisabeth P.,Reid Alistair G.

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference16 articles.

1. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining;Rowley;Nature,1973

2. Chronic myeloid leukaemia as a model of disease evolution in human cancer;Melo;Nat Rev Cancer,2007

3. Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia;Reid;Br J Haematol,2003

4. Translocation of c-abl to “masked” Ph in chronic myeloid leukemia;Hagemeijer;Cancer Genet Cytogenet,1985

5. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia;Sinclair;Blood,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCR/ABL1 fluorescence in situ hybridization fusion signals on both copies of chromosome 22 in a Philadelphia-masked chronic myeloid leukemia case: implication for the therapy;Hematology Reports;2021-03-24

2. Characterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center study;Leukemia & Lymphoma;2019-08-07

3. Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy;Oncotarget;2017-02-16

4. The genetics of chronic myelogenous leukaemia;The Genetic Basis of Haematological Cancers;2016-03-05

5. Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutation;Blood Cancer Journal;2013-03